Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omnicell (OMCL) Gains from Investment Securities (2016 - 2025)

Omnicell (OMCL) has disclosed Gains from Investment Securities for 13 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities rose 34.14% to $1.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $10.4 million, a 114.98% increase, with the full-year FY2025 number at $7.7 million, up 59.19% from a year prior.
  • Gains from Investment Securities was $1.7 million for Q4 2025 at Omnicell, down from $2.6 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $4.8 million in Q3 2024 to a low of -$8.2 million in Q4 2023.
  • A 5-year average of $1.4 million and a median of $2.3 million in 2021 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: plummeted 499.27% in 2023, then surged 212.26% in 2024.
  • Omnicell's Gains from Investment Securities stood at $4.1 million in 2021, then plummeted by 49.3% to $2.1 million in 2022, then tumbled by 499.27% to -$8.2 million in 2023, then skyrocketed by 115.57% to $1.3 million in 2024, then soared by 34.14% to $1.7 million in 2025.
  • Per Business Quant, the three most recent readings for OMCL's Gains from Investment Securities are $1.7 million (Q4 2025), $2.6 million (Q3 2025), and $1.3 million (Q4 2024).